These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7093909)

  • 1. Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling.
    Meyer JS; Connor RE
    Cancer; 1982 Aug; 50(4):746-51. PubMed ID: 7093909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.
    Wellings SR; Jensen HM; Marcum RG
    J Natl Cancer Inst; 1975 Aug; 55(2):231-73. PubMed ID: 169369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Small focal lesions of the breast: a clinico-morphological analysis].
    Serov VV; Kuzin MI; Zolotarevskiĭ VB; Zal'tsman IN; Kulakova AM
    Arkh Patol; 1984; 46(9):25-32. PubMed ID: 6095796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of benign proliferative breast disease.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
    Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones.
    Meyer JS
    Hum Pathol; 1977 Jan; 8(1):67-81. PubMed ID: 844855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear morphometry of benign and malignant breast lesions.
    Skjørten F; Kaaresen R; Jacobsen U; Skaane P; Amlie E
    Eur J Surg Oncol; 1991 Aug; 17(4):350-3. PubMed ID: 1874292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG; Rohan TE
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pathologic study of benign breast diseases in Tokyo and New York.
    Schuerch C; Rosen PP; Hirota T; Itabashi M; Yamamoto H; Kinne DW; Beattie EJ
    Cancer; 1982 Nov; 50(9):1899-903. PubMed ID: 7116314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P
    Cancer; 1993 Jun; 71(12):3908-13. PubMed ID: 8508356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
    Kamel OW; Franklin WA; Ringus JC; Meyer JS
    Am J Pathol; 1989 Jan; 134(1):107-13. PubMed ID: 2536520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of proliferative breast lesions around breast cancers].
    Moriya T; Manabe T; Sakurai T; Sakamoto K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
    Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
    Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Aaman TB; Stalsberg H; Thomas DB
    Int J Cancer; 1997 May; 71(3):333-9. PubMed ID: 9139863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.
    Lellé RJ; Heidenreich W; Stauch G; Wecke I; Gerdes J
    J Cancer Res Clin Oncol; 1987; 113(1):73-7. PubMed ID: 3818781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management.
    Calhoun BC; Booth CN
    Hum Pathol; 2014 Oct; 45(10):2130-5. PubMed ID: 25106711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphology of dysplasia and small cancer of the breast].
    Ermilova VD; Zolotarevskiĭ VB; Delektorskaia VV; Raĭkhlin NT
    Arkh Patol; 1985; 47(11):43-51. PubMed ID: 3004395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast.
    Jacquemier JD; Rolland PH; Vague D; Lieutaud R; Spitalier JM; Martin PM
    Cancer; 1982 Jun; 49(12):2534-6. PubMed ID: 7074570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-tumoral breast tissue in breast-cancer patients: variations with a family history of breast cancer. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Aaman TB; Stalsberg H; Thomas DB
    Int J Cancer; 1998 Feb; 79(1):39-43. PubMed ID: 9495356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.